| Şizofreni ve tedavisi D Summakoğlu, B Ertuğrul Lectio Scientific 2 (1), 43-61, 2018 | 42 | 2018 |
| A strong relationship between oral squamous cell carcinoma and DNA repair genes H Avci, A Ergen, ES Bireller, B Ertugrul, B Cakmakoglu Biochemical genetics 55, 378-386, 2017 | 24 | 2017 |
| The apoptotic efficacy of succinic acid on renal cancer cell lines G Kasarci, B Ertugrul, ES Iplik, B Cakmakoglu Medical Oncology 38 (12), 144, 2021 | 16 | 2021 |
| In vitro inhibitory effect of succinic acid on T-cell acute lymphoblastic leukemia cell lines B Ertugrul, ES Iplik, B Cakmakoglu Archives of Medical Research 52 (3), 270-276, 2021 | 14 | 2021 |
| An answer to colon cancer treatment by mesenchymal stem cell originated from adipose tissue ES Iplik, B Ertugrul, I Kozanoglu, Y Baran, B Cakmakoglu Iranian Journal of Basic Medical Sciences 21 (5), 465, 2018 | 14 | 2018 |
| Apoptotic effects of acacetin in human colon cancer HT-29 and HCT 116 cells BT Aslan, B Ertugrul, ES Iplik, B Cakmakoglu Journal of Cancer Research and Therapeutics 17 (6), 1479-1482, 2021 | 7 | 2021 |
| Schizophrenia and its treatment D Summakoğlu, B Ertuğrul Lectio Scientific Journal of Health and Natural Sciences 1 (2), 43-61, 2018 | 6 | 2018 |
| Betulinic acid may modulate autophagy in renal cell carcinoma cells B Atas, B ERTUĞRUL, E Iplik, B ÇAKMAKOĞLU, H ERGEN BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY 124 (2), 2023 | 4 | 2023 |
| The inhibitory effect of betulinic acid on epithelial–mesenchymal transition pathway in renal cell carcinoma MN Ataş, B Ertuğrul, ES İplik, B Çakmakoğlu, A Ergen Medical Oncology 39 (11), 170, 2022 | 3 | 2022 |
| ROS related enzyme levels and its association to molecular signaling pathway in the development of head and neck cancer ES Iplik, B Ertugrul, G Candan, S Pamuk, L Aydemir, M Celik, M Ulusan, ... Cellular and Molecular Biology 64 (7), 24-29, 2018 | 3 | 2018 |
| Examination of the apoptotic effects of betulinic acid on renal cancer cell lines A Ergen, ES Iplık, B Ertugrul, MN Atas, G Kasarcı, B Cakmakoglu Marmara Medical Journal 33 (3), 113-118, 2020 | 2 | 2020 |
| Effects of betulinic acid on AKT/mTOR pathway in renal cell carcinoma MN Ataş, B Ertuğrul, ES Iplik, B Çakmakoğlu, A Ergen Turkish Journal of Urology 48 (1), 58, 2022 | 1 | 2022 |
| Levofloxacin might be safe to use for OSCC patients L Aydemir, ES Iplik, B Ertugrul, G Kasarci, MN Atas, M Ulusan, A Ergen, ... Medical Oncology 38 (8), 87, 2021 | 1 | 2021 |
| Hesperidin triggering apoptosis on neuroblastoma cell T Çatmakaş, B Ertuğrul, ES İplik, B Çakmakoğlu Archives of Clinical and Experimental Medicine 3 (3), 123-126, 2018 | 1 | 2018 |
| Focusing on tumor and it’s microenvironmental immune members for head and neck cancer patients S Pamuk, B Ertugrul, G Kasarci, S Bireller, A Ergen, B Cakmakoglu, ... Pathology-Research and Practice 263, 155575, 2024 | | 2024 |
| BAŞ BOYUN KANSERLERİNDE ONKOGENLER VE TÜMÖR BASKILAYICI GENLER G Bayramova, B Ertugrul, G Kaşarcı, S Bireller, B Çakmakoğlu Acta Medica Nicomedia 7 (3), 362-367, 2024 | | 2024 |
| The Effects of Pentoxifylline Administration on TGF-β1 Expression in Rats with Radiation-Induced Muscle Fibrosis G GASIMLI, M DEMIR, B ERTUGRUL, B CAKMAKOGLU, HB BECERIR, ... International Journal of Hematology and Oncology 34 (2), 093-101, 2024 | | 2024 |
| What if amoxicillin/clavulanic acid reduces the cisplatin anticancer impact on oral cancer treatment? M Ulusan, S Bireller, B Ertugrul, G Kasarci, MN Atas, L Aydemir, A Ergen, ... Journal of Stomatology, Oral and Maxillofacial Surgery 124 (6), 101502, 2023 | | 2023 |
| The association of epidermal growth factor variant with oral squamous cell carcinoma B Ertugrul, A Mohammed, G Kasarci, S Bireller, M Ulusan, B Cakmakoglu Environmental and Molecular Mutagenesis 64 (8-9), 473-479, 2023 | | 2023 |
| HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?* MMP 9 VE TIMP 1 GENETİK VARYANTLARI VE VİTAMİN D NAZAL … M KILIÇOĞLU, B ERTUĞRUL, G KAŞARCI, Ş ÇOMOĞLU, L AYDEMİR, ... Istanbul Tip Fakultesi Dergisi 86 (2), 2023 | | 2023 |
